Skip to main content
Premium Trial:

Request an Annual Quote

Bill Hancock, Christine Arakelian

Premium

Bill Hancock, currently vice president of proteomics at Thermo Finnigan, told ProteoMonitor last week that he will move to Northeastern University in Boston in November, taking up a post as professor of chemistry at the Barnett Institute and department of chemistry. He will be focusing on clinical proteomics. Hancock’s previous positions include principal scientist at HP/Agilent Laboratories and director of analytical chemistry at Genentech. He holds PhD and DSc degrees in chemistry from the University of Adelaide in Australia.

Christine Arakelian has joined Large Scale Biology Corporation as senior director for business development. She will be based in the company’s Germantown, Md., office. Most recently, Arakelian worked as an independent consultant for biotechnology companies, focusing on strategy and business development. She has also practiced as an attorney and worked for the US State Department and the CIA on science and technology matters. She holds degrees from the University of Pennsylvania and the University of Virginia School of Law.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.